SLP

Simulations Plus Inc.

Price

$18.42

return (12m)

22.39%

p/e

45.93

p/bv

2.68

DIVIDEND YIELD

0.00%

SLP price

Simulations Plus

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SLP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.35%

3 months

12.52%

1 year

22.39%

2 years

-43.32%

5 years

-57.07%

10 years

124.59%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SLP

Valuation

P/E

45.93

Sector 0.30

Industry 2.11

P/BV

2.68

Sector 1.85

Industry 2.24

P/Revenue (PSR)

4.54

Sector 1.55

Industry 1.78

EV/EBITDA

54.93

Sector -47.98

Industry -1.11

EV/EBIT

71.63

Sector -34.76

Industry -8.71

P/EBITDA

21.75

Sector -37.73

Industry -54.67

P/EBIT

32.37

Sector -43.70

Industry -52.63

P/Total Assets

2.43

Sector 0.88

Industry 1.00

P/Net Current Assets

6.08

Sector -27.97

Industry -10.95

P/Working Capital

6.05

Sector -3.40

Industry 1.40

EPS

0.40

Sector -0.77

Industry -0.69

BVPS

6.88

Sector 4.04

Industry 4.67

Efficiency

Gross Margin

63.38%

Sector 48.57%

Industry 49.58%

EBITDA Margin

26.81%

Sector -310.04%

Industry -56.64%

EBIT Margin

20.56%

Sector -179.86%

Industry -55.50%

Operating Margin

14.02%

Sector -21.72%

Industry -27.73%

Net Profit Margins

9.88%

Sector -26.17%

Industry -31.12%

Asset Turnover

0.14

Sector 0.13

Industry 0.15

Profitability

ROE

5.83%

Sector -27.31%

Industry -25.93%

ROA

5.30%

Sector -25.75%

Industry -26.03%

ROIC

13.25%

Sector -590.50%

Industry -95.34%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.54

Sector 1.92

Industry 2.01

Net Debt / EBITDA

-8.52

Sector -23.56

Industry -2.23

Net Debt / EBIT

-11.11

Sector -3.30

Industry -1.54

Net Debt / Equity

-0.36

Sector -0.69

Industry -0.28

Gross Debt / Equity

0.00

Sector 0.09

Industry -0.81

Equity/Assets

0.91

Sector 0.45

Industry 0.46

Liabilities/Assets

0.09

Sector 0.49

Industry 0.52

Growth

5Y Revenue CAGR

11.24%

Sector -

Industry -

5Y Earnings CAGR

-4.73%

Sector -

Industry -

Fundamentals SLP

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Simulations Plus ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$18.42

Fair Value

$7.87

Upside Return potential.

-57.28%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SLP Simulations Plus Inc.	$18.42	22.39%	0.00%	45.93	2.68	5.83%	9.88%
OPRX OptimizeRx Corporation	$7.29	-57.93%	0.00%	28.83	1.01	3.51%	4.66%
RVTY Revvity Inc.	$124.31	50.50%	0.23%	57.83	1.91	3.31%	8.22%
LLY Eli Lilly and Compay	$1,115.70	48.63%	0.59%	37.57	29.62	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$369.15	-17.91%	0.00%	41.36	7.14	17.26%	28.62%
SNY Sanofi	$42.77	-5.47%	4.16%	3.98	0.73	18.43%	14.25%
NVS Novartis AG	$137.16	12.65%	2.25%	20.58	6.25	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$609.82	27.74%	0.29%	32.54	4.31	13.25%	15.07%
ABT Abbott Laboratories	$101.95	-22.02%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$90.96	0.64%	3.17%	21.85	2.26	10.35%	14.02%
GSK GlaxoSmithKline PLC	$48.13	23.26%	3.68%	14.78	4.17	28.24%	14.54%
BSX Boston Scientific Corp.	$42.98	-58.15%	0.00%	17.35	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$82.18	-28.27%	0.00%	18.39	5.39	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$504.70	-21.28%	0.00%	34.83	24.62	70.67%	25.03%
RMD ResMed Inc.	$218.27	-18.17%	1.11%	20.57	4.76	23.13%	26.94%
HCA HCA Healthcare Inc.	$426.94	6.08%	0.70%	11.97	-29.30	-244.72%	10.07%
COHR Coherent Inc.	$305.37	196.50%	0.00%	74.57	5.29	7.09%	11.19%
DHR Danaher Corporation	$200.14	6.09%	0.71%	35.51	2.70	7.61%	15.95%
SYK Stryker Corp.	$275.56	-27.17%	1.29%	27.75	4.31	15.55%	14.43%
PHG Koninklijke Philips NV	$24.60	-9.33%	4.12%	18.14	1.78	9.80%	6.30%
CI Cigna Corp.	$280.76	-4.70%	2.22%	10.69	1.72	16.04%	2.42%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SLP Historical Dividends

current DY: 0.00%

5-year average DY: 0.54%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/26/2024	08/05/2024	0.06000000
Dividends	04/25/2024	05/06/2024	0.06000000
Dividends	01/25/2024	02/05/2024	0.06000000
Dividends	10/26/2023	11/06/2023	0.06000000
Dividends	07/27/2023	08/07/2023	0.06000000
Dividends	04/20/2023	05/01/2023	0.06000000
Dividends	01/26/2023	02/06/2023	0.06000000
Dividends	10/27/2022	11/07/2022	0.06000000
Dividends	07/21/2022	08/01/2022	0.06000000
Dividends	04/21/2022	05/02/2022	0.06000000
Dividends	01/27/2022	02/07/2022	0.06000000
Dividends	10/21/2021	11/01/2021	0.06000000
Dividends	07/22/2021	08/02/2021	0.06000000
Dividends	04/22/2021	05/03/2021	0.06000000
Dividends	01/21/2021	02/01/2021	0.06000000
Dividends	10/22/2020	11/02/2020	0.06000000
Dividends	07/23/2020	08/03/2020	0.06000000
Dividends	04/22/2020	05/01/2020	0.06000000
Dividends	01/23/2020	02/03/2020	0.06000000
Dividends	10/23/2019	11/01/2019	0.06000000
Dividends	07/23/2019	08/01/2019	0.06000000
Dividends	04/22/2019	05/01/2019	0.06000000
Dividends	01/23/2019	02/01/2019	0.06000000
Dividends	10/30/2018	11/08/2018	0.06000000
Dividends	07/24/2018	08/02/2018	0.06000000
Dividends	04/23/2018	05/02/2018	0.06000000
Dividends	01/24/2018	02/02/2018	0.06000000
Dividends	11/09/2017	11/20/2017	0.06000000
Dividends	07/26/2017	08/04/2017	0.05000000
Dividends	05/04/2017	05/15/2017	0.05000000
Dividends	01/26/2017	02/06/2017	0.05000000
Dividends	11/08/2016	11/17/2016	0.05000000
Dividends	08/09/2016	08/18/2016	0.05000000
Dividends	04/28/2016	05/09/2016	0.05000000
Dividends	01/27/2016	02/05/2016	0.05000000
Dividends	11/05/2015	11/16/2015	0.05000000
Dividends	07/21/2015	07/30/2015	0.05000000
Dividends	05/07/2015	05/18/2015	0.05000000
Dividends	01/22/2015	02/02/2015	0.05000000
Dividends	11/05/2014	11/14/2014	0.05000000
Dividends	07/31/2014	08/11/2014	0.05000000
Dividends	05/07/2014	05/16/2014	0.05000000
Dividends	02/13/2014	02/24/2014	0.05000000
Dividends	11/06/2013	11/15/2013	0.04000000
Dividends	08/08/2013	08/15/2013	0.03000000
Dividends	05/03/2013	05/10/2013	0.03000000
Dividends	12/20/2012	12/28/2012	0.14000000
Dividends	11/06/2012	11/13/2012	0.05000000
Dividends	08/03/2012	08/10/2012	0.05000000
Dividends	04/25/2012	05/08/2012	0.05000000
Dividends	02/17/2012	03/01/2012	0.05000000

ABOUT Simulations Plus

Simulations Plus Inc.

Average Investor10 user rating

4.0 (2 people)

United States

30 years

Founded: 1996

1997

Time since IPO - 29 years

137

Employees

Simulations Plus Inc. (United States) is listed on the Nasdaq and has a market capitalization of $372.25 million, with shareholders equity totaling $139.04 million.

The company employs approximately 137 people and operates in the Health sector, within the Health Technology industry.

Over the past 12 months, Simulations Plus Inc. reported $82.06 million in revenue, generating net income of $8.11 million.

Key financial metrics include a P/E ratio of 45.93, a price-to-book (P/B) ratio of 2.68, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLP.

Market cap

$372.25 million

Net worth

$139.04 million

$139,035,000.00

Assets

$152.98 million

$152,976,000.00

Total Shares Outstanding

20.21 million

20,209,000

Average Daily Trading Volume

$307.30 Thousand

$307,298.00

Sector

Health

Industry

Health Technology

SLP

SLP revenue and profits

Financial Results SLP

DRAG THE FRAME TO SEE MORE DATA

SLP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.66 30,24% (12M)

P/E

-0.84

2.82%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$280.76 --4,70% (12M)

P/E

10.69

2.22%

ROE

16.04%

P/BV

1.72

CNC - Centene

$66.42 99,70% (12M)

P/E

-6.30

0.00%

ROE

-22.56%

P/BV

1.42

HUM - Humana

$409.80 50,71% (12M)

P/E

37.65

0.87%

ROE

6.72%

P/BV

2.53

SNY - Sanofi

$42.77 --5,47% (12M)

P/E

3.98

4.16%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,115.70 48,63% (12M)

P/E

37.57

0.59%

ROE

78.84%

P/BV

29.62

HCA - HCA Healthcare

$426.94 6,08% (12M)

P/E

11.97

0.70%

ROE

-244.72%

P/BV

-29.30

NVS - Novartis

$137.16 12,65% (12M)

P/E

20.58

2.25%

ROE

30.39%

P/BV

6.25

CVS - CVS Health

$94.66 30,24% (12 M)

P/L

-0.84

2.82%

ROE

-178.93%

P/VP

1.51

CI - Cigna

$280.76 --4,70% (12 M)

P/L

10.69

2.22%

ROE

16.04%

P/VP

1.72

CNC - Centene

$66.42 99,70% (12 M)

P/L

-6.30

0.00%

ROE

-22.56%

P/VP

1.42

HUM - Humana

$409.80 50,71% (12 M)

P/L

37.65

0.87%

ROE

6.72%

P/VP

2.53

SNY - Sanofi

$42.77 --5,47% (12 M)

P/L

3.98

4.16%

ROE

18.43%

P/VP

0.73

LLY - Eli Lilly

$1,115.70 48,63% (12 M)

P/L

37.57

0.59%

ROE

78.84%

P/VP

29.62

HCA - HCA Healthcare

$426.94 6,08% (12 M)

P/L

11.97

0.70%

ROE

-244.72%

P/VP

-29.30

NVS - Novartis

$137.16 12,65% (12 M)

P/L

20.58

2.25%

ROE

30.39%

P/VP

6.25

Frequently Asked Questions

What is the price of Simulations Plus (SLP) today?

A cotação de Simulations Plus (SLP) hoje está em US$ 18.42, com uma variação de 22.39% em relação ao último ano. A cotação de Simulations Plus (SLP) iniciou o ano negociando na casa dos US$ 18.23 e hoje está em US$ 18.42. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Simulations Plus (SLP) e dados de ações do Ibovespa e mercados internacionais.

Quando Simulations Plus (SLP) paga dividendos?

Simulations Plus (SLP) não distribuiu dividendos no último ano.

Is Simulations Plus (SLP) a good investment?

Atualmente, Simulations Plus (SLP) está cotada a US$ 18.42, com um P/L de 45.93, representando um desvio de 5,968% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 22.39 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 22.39%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Simulations Plus (SLP) stock?

Investir em ações de Simulations Plus (SLP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Simulations Plus (SLP) yield today?

A rentabilidade de Simulations Plus (SLP) foi de 0.35% no último mês, 22.39% no último ano e -57.07% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Simulations Plus (SLP) hoje, o investimento total seria de US$ 1,842.00, com base na cotação atual de US$ 18.42.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,254.42
Em 5 anos: US$ 790.77
Em 10 anos: US$ 4,136.95

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SLP

Simulations Plus Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SLP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING SLP WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.54%

type

Ex - Dividend Date

payment date

value

ABOUT Simulations Plus

Simulations Plus Inc.

United States

30 years

1997

137

PROFIT X PRICE SLP

Financial Results SLP

SLP cash flow

Asset, Revenue and Profit Growth - SLP

SLP balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions